Form 8-K - Current report:
SEC Accession No. 0000947871-21-001217
Filing Date
2021-11-18
Accepted
2021-11-18 09:06:48
Documents
15
Period of Report
2021-11-17
Items
Item 2.06: Material Impairments
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ss621297_8k.htm   iXBRL 8-K 29722
2 PRESS RELEASE ss621297_ex9901.htm EX-99.1 29043
3 GRAPHIC image_001.jpg GRAPHIC 1465
4 GRAPHIC image_002.jpg GRAPHIC 9270
  Complete submission text file 0000947871-21-001217.txt   254525

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cvs-20211117.xsd EX-101.SCH 2995
6 XBRL LABEL FILE cvs-20211117_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE cvs-20211117_pre.xml EX-101.PRE 22340
8 EXTRACTED XBRL INSTANCE DOCUMENT ss621297_8k_htm.xml XML 3477
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

EIN.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01011 | Film No.: 211422737
SIC: 5912 Retail-Drug Stores and Proprietary Stores